BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18583621)

  • 1. The association of advanced glycation end-products with glutathione status.
    Sahin E; Göçmen AY; Koçak H; Tuncer M; Gümüslü S
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):369-74. PubMed ID: 18583621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus.
    Bravi MC; Armiento A; Laurenti O; Cassone-Faldetta M; De Luca O; Moretti A; De Mattia G
    Metabolism; 2006 May; 55(5):691-5. PubMed ID: 16631447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Picrorhiza scrophulariiflora improves accelerated atherosclerosis through inhibition of redox-sensitive inflammation.
    Guo ZJ; Hou FF; Liu SX; Tian JW; Zhang WR; Xie D; Zhou ZM; Liu ZQ; Zhang X
    Int J Cardiol; 2009 Aug; 136(3):315-24. PubMed ID: 19178960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
    Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress markers in pre-uremic patients.
    Annuk M; Fellström B; Akerblom O; Zilmer K; Vihalemm T; Zilmer M
    Clin Nephrol; 2001 Oct; 56(4):308-14. PubMed ID: 11680661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end-products in sickle cell anaemia.
    Somjee SS; Warrier RP; Thomson JL; Ory-Ascani J; Hempe JM
    Br J Haematol; 2005 Jan; 128(1):112-8. PubMed ID: 15606557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end product free adducts are cleared by dialysis.
    Agalou S; Ahmed N; Thornalley PJ; Dawnay A
    Ann N Y Acad Sci; 2005 Jun; 1043():734-9. PubMed ID: 16037300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
    Dave GS; Kalia K
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation.
    Liu SX; Hou FF; Guo ZJ; Nagai R; Zhang WR; Liu ZQ; Zhou ZM; Zhou M; Xie D; Wang GB; Zhang X
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1156-62. PubMed ID: 16497990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione and lipid peroxide changes in pseudoexfoliation syndrome.
    Gartaganis SP; Georgakopoulos CD; Patsoukis NE; Gotsis SS; Gartaganis VS; Georgiou CD
    Curr Eye Res; 2005 Aug; 30(8):647-51. PubMed ID: 16109644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between proinsulin-to-insulin ratio and advanced glycation endproducts in Japanese type 2 diabetic subjects.
    Saisho Y; Maruyama T; Hirose H; Saruta T
    Diabetes Res Clin Pract; 2007 Nov; 78(2):182-8. PubMed ID: 17467843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.
    Sebeková K; Gazdíková K; Syrová D; Blazícek P; Schinzel R; Heidland A; Spustová V; Dzúrik R
    J Hum Hypertens; 2003 Apr; 17(4):265-70. PubMed ID: 12692571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of alpha-lipoic acid on LPS-induced oxidative stress in the heart.
    Goraca A; Piechota A; Huk-Kolega H
    J Physiol Pharmacol; 2009 Mar; 60(1):61-8. PubMed ID: 19439808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased levels of advanced glycation end-products in patients with Gilbert syndrome.
    Kalousová M; Novotny L; Zima T; Braun M; Vítek L
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(4):387-92. PubMed ID: 16309589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
    Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
    Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians.
    Sebeková K; Boor P; Valachovicová M; Blazícek P; Parrák V; Babinská K; Heidland A; Krajcovicová-Kudlácková M
    Mol Nutr Food Res; 2006 Sep; 50(9):858-68. PubMed ID: 16917805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation endproducts (AGEs) as uremic toxins.
    Schwenger V; Zeier M; Henle T; Ritz E
    Nahrung; 2001 Jun; 45(3):172-6. PubMed ID: 11455783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications.
    Bansal S; Chawla D; Siddarth M; Banerjee BD; Madhu SV; Tripathi AK
    Clin Biochem; 2013 Jan; 46(1-2):109-14. PubMed ID: 23103709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification.
    Li SY; Du M; Dolence EK; Fang CX; Mayer GE; Ceylan-Isik AF; LaCour KH; Yang X; Wilbert CJ; Sreejayan N; Ren J
    Aging Cell; 2005 Apr; 4(2):57-64. PubMed ID: 15771609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.